They were randomly assigned to group I ( n = @ ; intra-arterial infusion of rAd-p@ plus chemotherapy ) , group II ( n = @ ; intra-arterial infusion of rAd-p@ plus placebo chemotherapy ) , or group III ( n = @ ; intra-arterial infusion of placebo rAd-p@ plus chemotherapy ) .